Evidence map›Paper›PMID 24386356›Full record

ArticlePloS one2013

Gene features selection for three-class disease classification via multiple orthogonal partial least square discriminant analysis and S-plot using microarray data.

Mingxing Yang, Xiumin Li, Zhibin Li, Zhimin Ou, Ming Liu, Suhuan Liu, Xuejun Li, Shuyu Yang

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mingxing YangXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China ; Department of Electronic Science, School of Physics and Mechanical & Electrical Engineering, Xiamen University, Xiamen, China.
Xiumin LiXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Zhibin LiXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Zhimin OuXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Ming LiuXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Suhuan LiuXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Xuejun LiXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China ; Department of Endocrinology and Diabetes, the First Affiliated Hospital of Xiamen University, Xiamen, China.
Shuyu YangXiamen Diabetes Institute, the First Affiliated Hospital of Xiamen University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationDNA microarray analysis is characterized by obtaining a large number of gene variables from a small number of observations. Cluster analysis is widely used to analyze DNA microarray data to make classification and diagnosis of disease. Because there are so many irrelevant and insignificant genes in a dataset, a feature selection approach must be employed in data analysis. The performance of cluster analysis of this high-throughput data depends on whether the feature selection approach chooses the most relevant genes associated with disease classes.

resultsHere we proposed a new method using multiple Orthogonal Partial Least Squares-Discriminant Analysis (mOPLS-DA) models and S-plots to select the most relevant genes to conduct three-class disease classification and prediction. We tested our method using Golub's leukemia microarray data. For three classes with subtypes, we proposed hierarchical orthogonal partial least squares-discriminant analysis (OPLS-DA) models and S-plots to select features for two main classes and their subtypes. For three classes in parallel, we employed three OPLS-DA models and S-plots to choose marker genes for each class. The power of feature selection to classify and predict three-class disease was evaluated using cluster analysis. Further, the general performance of our method was tested using four public datasets and compared with those of four other feature selection methods. The results revealed that our method effectively selected the most relevant features for disease classification and prediction, and its performance was better than that of the other methods.

Indexed as

Oligonucleotide Array Sequence AnalysisCluster AnalysisComputational BiologyDiscriminant AnalysisHumansLeast-Squares AnalysisLeukemiaPrincipal Component AnalysisReproducibility of Results

Identifiers

PMID24386356
PMCPMC3875537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.